Obesity Increases Mitogen-Activated Protein Kinase Phosphatase-3 Levels in the Hypothalamus of Mice
- PMID: 29062272
- PMCID: PMC5640777
- DOI: 10.3389/fncel.2017.00313
Obesity Increases Mitogen-Activated Protein Kinase Phosphatase-3 Levels in the Hypothalamus of Mice
Abstract
Mitogen-activated Protein Kinase Phosphatase 3 (MKP-3) has been involved in the negative regulation of insulin signaling. The absence of MKP-3 is also associated with reduced adiposity, increased energy expenditure and improved insulin sensitivity. The MKP-3 is known as the main Erk1/2 phosphatase and FoxO1 activator, which has repercussions on the gluconeogenesis pathway and hyperglycemia in obese mice. Recently, we showed that MKP-3 overexpression decreases FoxO1 phosphorylation in the hypothalamus of lean mice. However, the hypothalamic interaction between MKP-3 and FoxO1 during obesity was not investigated yet. Here, the MKP-3 expression and the effects on food intake and energy expenditure, were investigated in high-fat diet-induced obese mice. The results indicate that obesity in mice increased the MKP-3 protein content in the hypothalamus. This hypothalamic upregulation led to an increase of food intake, adiposity, and body weight. Furthermore, the obese mice with increased MKP-3 showed an insulin signaling impairment with reduction of insulin-induced FoxO1 and Erk1/2 phosphorylation in the hypothalamus. Moreover, a bioinformatics analysis of data demonstrated that hypothalamic MKP-3 mRNA levels were positively correlated with body weight and negatively correlated to oxygen consumption (VO2) in BXD mice. Taken together, our study reports that obesity is associated with increased protein levels of hypothalamic MKP-3, which is related to the reduction of FoxO1 and Erk1/2 phosphorylation in the hypothalamus as well as to an increase in body weight and a reduction in energy expenditure.
Keywords: MKP-3; food intake; hypothalamus; insulin; obesity.
Figures






Similar articles
-
Overexpression of Mitogen-activated protein kinase phosphatase-3 (MKP-3) reduces FoxO1 phosphorylation in mice hypothalamus.Neurosci Lett. 2017 Oct 17;659:14-17. doi: 10.1016/j.neulet.2017.08.067. Epub 2017 Sep 1. Neurosci Lett. 2017. PMID: 28866049
-
Mitogen-activated protein kinase phosphatase 3 (MKP-3)-deficient mice are resistant to diet-induced obesity.Diabetes. 2014 Sep;63(9):2924-34. doi: 10.2337/db14-0066. Epub 2014 Apr 10. Diabetes. 2014. PMID: 24722245 Free PMC article.
-
Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice.Endocrinology. 2012 Sep;153(9):4401-11. doi: 10.1210/en.2012-1272. Epub 2012 Jul 20. Endocrinology. 2012. PMID: 22822160
-
Leptin signaling, adiposity, and energy balance.Ann N Y Acad Sci. 2002 Jun;967:379-88. doi: 10.1111/j.1749-6632.2002.tb04293.x. Ann N Y Acad Sci. 2002. PMID: 12079865 Review.
-
Roles of FoxO1 and Sirt1 in the central regulation of food intake.Endocr J. 2010;57(11):939-46. doi: 10.1507/endocrj.k10e-320. Epub 2010 Oct 30. Endocr J. 2010. PMID: 21048357 Review.
Cited by
-
A platform for experimental precision medicine: The extended BXD mouse family.Cell Syst. 2021 Mar 17;12(3):235-247.e9. doi: 10.1016/j.cels.2020.12.002. Epub 2021 Jan 19. Cell Syst. 2021. PMID: 33472028 Free PMC article.
-
Changes of Signaling Pathways in Hypothalamic Neurons with Aging.Curr Issues Mol Biol. 2023 Oct 12;45(10):8289-8308. doi: 10.3390/cimb45100523. Curr Issues Mol Biol. 2023. PMID: 37886966 Free PMC article. Review.
-
Potential Pharmaceutical Applications of Quercetin in Cardiovascular Diseases.Pharmaceuticals (Basel). 2022 Aug 18;15(8):1019. doi: 10.3390/ph15081019. Pharmaceuticals (Basel). 2022. PMID: 36015169 Free PMC article. Review.
-
Impact of Conventional and Atypical MAPKs on the Development of Metabolic Diseases.Biomolecules. 2020 Aug 29;10(9):1256. doi: 10.3390/biom10091256. Biomolecules. 2020. PMID: 32872540 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous